Mitsui Chemicals completes tender offer for DNA Chip Research

Mitsui Chemicals (TSE:4183) announced the successful completion of its tender offer for common shares of DNA Chip Research Inc. (Securities Code 2397) following a board resolution on February 4, 2025. The tender offer, which commenced on February 5, 2025, and concluded on April 7, 2025, resulted in Mitsui Chemicals acquiring 3,669,512 shares. This acquisition fulfills the minimum share requirement of 3,119,000, leading Mitsui Chemicals to purchase all tendered shares at a price of JPY 1,100 per share. As a result of the tender offer, Mitsui Chemicals' ownership in DNA Chip Research has increased from 13.87% to 68.14%. Mitsui Chemicals intends to proceed with squeeze-out procedures to become the sole shareholder of DNA Chip Research, leading to the delisting of DNA Chip Research from the Standard Market of the TSE.